ArticleCell death & disease2025

Inhibition of Wnt/β-catenin increases anti-tumor activity by synergizing with sorafenib in hepatocellular carcinoma.

Yuchao He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.